Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Stephen Nimer
myeloid cancer biology
Julia Paczkowska
immunobiology of Hodgkin's disease
Grant Challen
preleukemia, leukemia
Amit Verma
AML/MDS
Christopher Booth
BPDCN
Frederick Locke
lymphoma and immunotherapy
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Carma Bylund
Equity in Access
Margaret Shipp
lymphoma biology
Jianguo Tao
Mantle Cell Lymphoma
Trent Hall
MDS
Tycel Phillips
Mantle Cell Lymphoma
Robert Soiffer
transplantation
Neha Mehta-Shah
T-cell lymphoma
Stephen Gottschalk
pediatric leukemia and CAR-T
Peter Croucher
Multiple Myeloma
Raymond Mailhot
Equity in Access
Daniel Thomas
Myelofibrosis
Ari Melnick
epigenetics and lymphoma
BioInvent International
immunotherapy, indolent NHL, CTCL
Bing Carter
p53 mutant AML
Jing Yang
Myeloma
Rachel Mersfelder
AMKL
Adam de Smith
pediatric ALL and Down Syndrome
Logan Spector
childhood leukemia epidimiology
John DiPersio
trispecific antibody for AML and MDS
Kerry Rogers
CLL
Sarah Tasian
pediatric leukemias
Robert Orlowski
(Smoldering) Multiple Myeloma
Affimed
immunotherapy, HL, PTCL
H. Irene Su
Equity in Access
Lori Muffly
Equity in Access
Lev Kats
myeloma and epigenetics
John Leonard
lymphoma research
Jing Fu
myeloma
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Siegfried Janz
Myeloma immunotherapy
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Meng Li
Equity in Access
Paolo Caimi
CAR-T clinical trial for CLL
Sam Butterworth
CMML
Adam Olszewski
Follicular and marginal zone lymphoma
Catherine Smith
leukemia
Mark Murakami
follicular lymphoma
Kirk Schultz
pediatric transplantation
Huda Salman
CMML
Gaurav Goyal
Erdheim-Chester Disease
Britta Will
Leukemia and pre-leukemia
Thomas LeBlanc
palliative care
Lindsey Montefiori
pediatric leukemia
Jenny Wang
AML
Tanya Siddiqi
clinical trial access
Yubin Zhou
peripheral T cell lymphoma
Qingyu Luo
BPDCN
Caner Saygin
T-ALL
F. Lennie Wong
Equity in Access
Solu Therapeutics
immunotherapy, CMML
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Julia Maxson
AML
Ravi Bhatia
transplantation
Riccardo Dalla-Favera
lymphoma (DLBCL)
Jake Shortt
precision therapy for aggressive lymphomas
Kimberly Stegmaier
childhood blood cancers
Christopher Porter
Leukemia, lymphoma
Bailee Kain
AML and African ancestry
Michael Kharas
leukemia
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Lawrence Boise
CART and myeloma
Jalpa Doshi
Equity in Access
Helen Parsons
Equity in Access
Hong Wen
AML
Nitin Jain
CLL
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Saar Gill
AML immunotherapy
Maximilian Stahl
AML immunotherapy
Qing Yi
Novel CAR-T
Liling Wan
AML
Ronald Levy
immunotherapies, COVID-19
Michael Savona
MDS and leukemia
Alfred Garfall
myeloma immunotherapy
Michael Keller
COVID-19, immunotherapy
Jun Qi
Myeloma
Brian Dalton
DNA mutations and myeloid cancers
Mark Dawson
B-ALL and CAR-T resistance
Christian Marinaccio
MLL leukemias
Xu Ji
Equity in Access
Daniel Herranz
T-ALL
Sergei Doulatov
Leukemias
Madhav Dhodapkar
multiple myeloma immunotherapy
Urvi Shah
Diet and myeloma
Nizar Bahlis
Myeloma immunotherapy
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Jolanta Grembecka
leukemia therapeutics
Ana Vujovic
AML
Wendy Stock
T-cell ALL
Matthew Frank
Lymphoma CART therapy
Michael Wang
Mantle Cell Lymphoma
Constellation Pharmaceuticals
myeloproliferative neoplasms
Shazia Nakhoda
Equity in Access
Nicoletta Cieri
AML and transplantation
Jayna Mistry
aging and leukemias
Jeffrey Magee
pediatric AML
Fenghuang Zhan
Myeloma and bone disease
Luca Busino
DLBCL
Teresa Palomero
Peripheral T-cell Lymphoma
Sriram Sundaravel
AML stem cells
Daisuke Nakada
preleukemia, leukemia
Jennifer Trowbridge
aging and leukemia
Simona Colla
Myeloma biology
Coleman Lindsley
AML/MDS
Brian Walker
smoldering myeloma, MGUS
Enterome
vaccine, FL, MZL
Elliot Stieglitz
CMML
Eirini Papapetrou
blood cancer stem cells
Pietro Genovese
transplant and AML
Ann-Kathrin Eisfeld
Racial diversity in AML
Catherine Bollard
pediatric blood cancers and immunotherapy
Pooja Khandelwal
bone marrow transplantation
Martin Dreyling
Mantle Cell Lymphoma
Megan McNerney
AML/MDS
Bruno Paiva
smoldering myeloma
Steven Horwitz
T-cell lymphomas
Nirav Shah
CAR-T for lymphoma
Mark Hamilton
DLBCL and CAR-T
Noemí Puig Morón
Myeloma
Marc Seifert
Hairy cell leukemia
George Vassiliou
Leukemia Prevention
Keisuke Ito
blood cancer stem cells and MDS metabolism
Michaela Reagan
Multiple Myeloma
Suman Paul
T cell cancers and immunotherapy
Alieen Rowan
Adult T cell leukemia/lymphoma
Taishi Yonezawa
AML
Shannon Maude
Immunotherapy for ALL
Faron Pharmaceuticals
immunotherapy, MDS
Jonas Jutzi
myeloproliferative neoplasms
Eric Padron
CMML
Sahand Hormoz
MPN
Richard Lock
T-ALL
Eugenio Morelli
Myeloma
Piers Patten
COVID-19
Armin Rashidi
gut bacteria and transplant success
Ricky Johnstone
lymphoma and myeloma
Rong Lu
preleukemia, leukemia
Paolo Strati
Non-Hodgkin Lymphoma
Enrico Tiacci
Hairy cell leukemia
Dimericon Therapeutics
dimericons, blood cancer
Randall Davis
CLL
Jeetayu Biswas
splicing in myeloid diseases
Soheil Meshinchi
pediatric AML
Omar Abdel-Wahab
Hairy cell leukemia
Nicolas Nassar
pediatric leukemia
Christopher Flowers
clinical trial access
Markus Muschen
leukemia and lymphoma biology
Rajni Kumari
AML
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Fahmin Basher
transplant and GvHD
Hao Jiang
DNA biology and leukemia
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Inhye Ahn
CLL
Jaehyuk Choi
T-cell lymphoma
Timothy Graubert
AML and MDS biology
Sham Mailankody
Myeloma immunotherapy clinical trials
Thomas Koehnke
leukemia
Ruben Carrasco
Myeloma
Reina Takeda
AML
Siddhartha Jaiswal
preleukemia
Yan Liu
MDS
Jeremy Baeten
AML
James Rubenstein
Lymphoma of the Central Nervous System
Courtney Jones
AML metabolism
Alexey Danilov
lymphoma
Sigurður Kristinsson
Smoldering myeloma
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Marco Ruella
Immunotherapy for T-cell lymphoma
Jennifer Amengual
lymphomas after transplant
Jonathon Cohen
lymphoma clinical trial access in Georgia
Steven Treon
Lymphomas and Waldenstrom's
Carl Allen
pediatric blood cancers
Wendy Béguelin
follicular lymphoma
Marina Konopleva
MDS/AML metabolism
Liran Shlush
pre-leukemia
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Gianpietro Dotti
CAR T and AML
Mendel Goldfinger
MDS/AML trials for the elderly
Rizwan Romee
Immunotherapy
Kathleen Sakamoto
pediatric AML
Jean Koff
Disparities in DLBCL
Lucy Godley
preleukemia
Leandro Cerchietti
DLBCL
Daniel Lucas
bone marrow and leukemia biology
Adi Nagler
Bronchiolitis obliterans after transplant
Craig Jordan
AML
Andrew Lane
BPDCN
Yibin Yang
Lymphoma
Alex Kentsis
pediatric leukemias
Paul Beavis
immunotherapy in myeloma
Takeshi Sugio
T-cell lymphoma
Cailin Collins
Leukemia and pre-leukemia
Thomas Kipps
Hairy Cell Leukemia
Peter Klein
MDS
John Crispino
myelofibrosis, pediatric leukemia and Downs
Anthony Letai
improving CAR-T
Jianhua Yu
myeloma immunotherapy
Nataly Cruz-Rodriguez
T-ALL and metabolism
Venkata Lokesh Battula
immunotherapy and AML
Catriona Jamieson
cancer stem cell biology
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Anushree Vichare
Equity in Access
Suzanne Lentzsch
Myeloma
Dan Landau
cancer evolution biology
Sheng Li
Aging and AML
George Daley
"off-the-shelf" CAR-T and CAR-NK
Michael Green
lymphoma biology
Paola Aguilar Neuville
Primary cutaneous γδ T-cell lymphoma
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Steven Park
follicular lymphoma
Tak Mak
Immunotherapy
William Matsui
Myeloma
Kasey Leger
pediatric blood cancers
Rgenta Therapeutics
RNA-targeting, blood cancer
Manyi Wei
acute megakaryoblastic leukemia
Tomasz Skorski
myeloproliferative neoplasms, AML
Yoke Seng Lee
AML
Koichi Takahashi
AML/MDS
Mala Shanmugam
myeloma
Jessica Stewart
Epstein-barr virus and lymphomas
Dane Vassiliadis
blood cancer biology
Srividya Swaminathan
pediatric, immunotherapy
Christian Steidl
B-cell lymphomas
Bingyi Chen
AML immunotherapy
Caron Jacobson
lymphoma and immunotherapy
Courtney DiNardo
clinical trials, AML
Roberta Zappasodi
lymphoma, immunotherapy
Joachim Yahalom
Lymphoma
Christine Zhang
AML
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Roland Walter
Antibody-based AML therapies
Grzegorz Nowakowski
Clinical trial access
Yiman Liu
Epigenetics and leukemia
Kura Oncology
MLL leukemia, AML
Ravindra Majeti
preleukemia, AML
Tyler Parsons
MPN and AML
Carl June
CAR T immunotherapy
Nicola Vannini
Aging and CAR-T success
Daniel Pollyea
AML
Eric Pietras
AML
Jennifer Woyach
CLL trials
ImCheck Therapeutics
immunotherapy, AML
Philippe Armand
follicular lymphoma
Caroline Arber
myeloma CAR-T
Oreofe Odejide
Equity in Access
Justine Kahn
pediatric leukemia and lymphoma
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Anouchka Laurent
T-cell lymphoma
Matteo Bellone
Smoldering multiple myeloma
Stacie Dusetzina
Equity in Access
Jonathan Licht
DNA biology, myeloma
Catherine Diefenbach
DLBCL immunology